Selective Neck Dissection Versus Modified Neck Dissection in PTC

This study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either the experimental group (selective neck dissection) or the control group (modified neck dissection), with LRFS as the primary endpoint. The aim of the study is to evaluate the safety of selective neck dissection in papillary carcinoma with limited number of lymph node metastases in the lateral neck, and the quality of life compared with modified neck dissection.

Trial Details

NCT ID
NCT06554652
Phase
PHASE3
Sponsor
Fudan University
Status
RECRUITING
Cancer Type
Papillary Thyroid Cancer
Interventions
  • Lymph node tracer navigated selective neck dissection
  • Modified neck dissection
Locations (sample)
  • Shanghai, China|31.22222,121.45806

Key Eligibility Criteria

  • Pathologically confirmed PTC;
  • Age range: 14-80 years old;
  • Preoperative fine needle aspiration confirms lymph node metastasis in the lateral neck
  • Ultrasound and CT suggest that metastatic/suspected metastatic lymph nodes are limited to compartment IV, with 1-2 lymph node metastases and \<1cm …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Papillary Thyroid Cancer Trials on Trialify →